Initial Treatment Strategies for Bronchiectasis and NTM Pulmonary Disease

In this episode, host Doreen Addrizzo-Harris, MD, FCCP, is joined by Keren Bakal, MD, and Amy Springer, MSN, FNP-C, to explore initial treatment strategies for bronchiectasis and nontuberculous mycobacteria (NTM) pulmonary disease. The conversation delves into the critical role of airway clearance therapy, challenges in selecting individualized treatments, and the importance of patient education. The experts also discuss the latest guidelines for managing nodular and cavitary NTM lung disease, including when to initiate treatment vs monitoring, as well as strategies for managing common drug toxicities. Additionally, they examine comorbidities often seen in patients with bronchiectasis, such as gastrointestinal disorders, sinus disease, and psychosocial factors like anxiety and depression.

This episode is part of CHEST's Bridging Specialties®: Timely Diagnosis for NTM Disease and Bronchiectasis program. LEARN MORE »

This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated.

 

HOST

Doreen J. Addrizzo-Harris, MD, FCCP

Fiona and Stanley Druckenmiller Professor of Pulmonary, Critical Care, and Sleep Medicine 

Director, NYULH Bronchiectasis and NTM Clinical and Translational Program

NYU Grossman School of Medicine

New York, NY

 

PANELISTS

Keren Bakal, MD

Clinical Attending, Pulmonary and Critical Care Medicine

Overlook Medical Center/Atlantic Health System

Summit Health

Livingston, NJ

 

Amy Springer, MSN, FNP-C

Senior Nurse Practitioner

NYULH Bronchiectasis and NTM Clinical and Translational Program 

Division of Pulmonary, Critical Care, and Sleep Medicine 

NYU Langone Health 

New York, NY